DEA schedule
Is digoxin a controlled substance?
Federal schedule for digoxin from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Digoxin is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and digoxin is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted digoxin?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 59 prescription listings from 30 labelers, none with a DEA schedule |
| DEA controlled substances list | digoxin is not on the list |
Digoxin NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0054-0057 | Digoxin | solution | .05 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 17856-0057 | Digoxin | solution | .05 mg/mL | Atlantic Biologicals Corps | None |
| 70515-262 | LANOXIN | injection, solution | 100 ug/mL | Covis Pharma US, Inc | None |
| 70515-263 | LANOXIN | injection, solution | 100 ug/mL | Covis Pharma US, Inc | None |
| 70515-260 | LANOXIN | injection, solution | 250 ug/mL | Covis Pharma US, Inc | None |
| 70515-261 | LANOXIN | injection, solution | 250 ug/mL | Covis Pharma US, Inc | None |
| 59212-240 | LANOXIN | tablet | .0625 mg/1 | Advanz Pharma (US) Corp. | None |
| 59212-242 | LANOXIN | tablet | .125 mg/1 | Advanz Pharma (US) Corp. | None |
| 71610-019 | LANOXIN | tablet | .125 mg/1 | Aphena Pharma Solutions - Tennessee, LLC | None |
| 59212-249 | LANOXIN | tablet | .25 mg/1 | Advanz Pharma (US) Corp. | None |
| 0404-9850 | Digoxin | injection | .25 mg/mL | Henry Schein, Inc. | None |
| 0641-1410 | Digoxin | injection | .25 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0641-6184 | Digoxin | injection | .25 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 51662-1217 | DIGOXIN | injection | .25 mg/mL | HF Acquisition Co LLC, DBA HealthFirst | None |
| 55154-5106 | Digoxin | injection | .25 mg/mL | Cardinal Health 107, LLC | None |
| 84549-410 | Digoxin | injection | .25 mg/mL | ProPharma Distribution | None |
| 0781-3059 | Digoxin | injection, solution | 250 ug/mL | Sandoz Inc | None |
| 71872-7325 | Digoxin | injection, solution | 250 ug/mL | Medical Purchasing Solutions, LLC | None |
| 66689-327 | Digoxin | solution | .05 mg/mL | VistaPharm, LLC | None |
| 69292-605 | Digoxin | solution | .05 mg/mL | Amici Pharma, Inc | None |
| 59651-436 | Digoxin | tablet | .0625 mg/1 | Aurobindo Pharma Limited | None |
| 70954-200 | Digoxin | tablet | .0625 mg/1 | ANI Pharmaceuticals, Inc. | None |
| 10135-747 | Digoxin | tablet | .125 mg/1 | Marlex Pharmaceuticals, Inc. | None |
| 50090-6708 | Digoxin | tablet | .125 mg/1 | A-S Medication Solutions | None |
| 50268-238 | Digoxin | tablet | .125 mg/1 | AvPAK | None |
| 51655-403 | Digoxin | tablet | .125 mg/1 | Northwind Health Company, LLC | None |
| 59651-437 | Digoxin | tablet | .125 mg/1 | Aurobindo Pharma Limited | None |
| 60687-858 | Digoxin | tablet | .125 mg/1 | American Health Packaging | None |
| 67046-1317 | Digoxin | tablet | .125 mg/1 | Coupler LLC | None |
| 70518-3859 | Digoxin | tablet | .125 mg/1 | REMEDYREPACK INC. | None |
| 70954-201 | Digoxin | tablet | .125 mg/1 | ANI Pharmaceuticals, Inc. | None |
| 10135-748 | Digoxin | tablet | .25 mg/1 | Marlex Pharmaceuticals, Inc. | None |
| 50090-7865 | Digoxin | tablet | .25 mg/1 | A-S Medication Solutions | None |
| 59651-438 | Digoxin | tablet | .25 mg/1 | Aurobindo Pharma Limited | None |
| 60687-869 | Digoxin | tablet | .25 mg/1 | American Health Packaging | None |
| 70518-3860 | Digoxin | tablet | .25 mg/1 | REMEDYREPACK INC. | None |
| 70954-202 | Digoxin | tablet | .25 mg/1 | ANI Pharmaceuticals, Inc. | None |
| 0115-9811 | Digoxin | tablet | 125 ug/1 | Amneal Pharmaceuticals of New York LLC | None |
| 0143-1240 | Digoxin | tablet | 125 ug/1 | Hikma Pharmaceuticals USA Inc. | None |
| 0615-8202 | Digoxin | tablet | 125 ug/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
Showing 40 of 59 listings.
Questions
Is digoxin a controlled substance?
No. Digoxin is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and digoxin is not on the DEA controlled substances list.
Is digoxin a narcotic?
No. Digoxin is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Cardiac Glycoside.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.